Thomas Marron, MD, PhD

Trials

Studies that name Thomas Marron, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:09 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07284485 · Immunoprevention for High-risk Lung Lesions

  Robert Samstein · recruiting · High-risk Lung Nodules · study chair
• Ph1/Ph2
  NCT07277322 · Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases

  Dan Feng · recruiting · Metastatic Colorectal Cancer, Liver Metastases · study chair
• Ph1
  NCT07058974 · A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation

  Icahn School of Medicine at Mount Sinai · active not recruiting · Smokers, Former Smokers · principal investigator
• Ph1/Ph2
  NCT06088771 · Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC

  Icahn School of Medicine at Mount Sinai · recruiting · Non-Small Cell Lung Cancer · principal investigator
• Ph1/Ph2
  NCT05013450 · Dupilumab_Metastatic NSCLC

  Thomas Marron · active not recruiting · Metastatic Non-small Cell Lung Cancer · principal investigator
• Ph2
  NCT04123379 · Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)

  Icahn School of Medicine at Mount Sinai · active not recruiting · Non-small Cell Lung Cancer, Hepatocellular Carcinoma

Grants

NIH projects from RePORTER, fetched 2026-11-12 13:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.